Zhou J - Search Results

1

[Role of novel risk factors in predicting risk of ischemic cardiovascular diseases in middle aged men in twenty years in Shanghai].

Jin X, Zhou J, Zhou J, Pan X, Chen H, Ge J. Jin X, et al. Among authors: zhou j. Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Mar;37(3):335-8. doi: 10.3760/cma.j.issn.0254-6450.2016.03.008. Zhonghua Liu Xing Bing Xue Za Zhi. 2016. PMID: 27005531 Chinese.

2

A new method for internal cardioversion in patients with persistent atrial fibrillation.

Zhou J, Sack S, Heinzel F, Hunold P, Dagres N, Erbel R, Ge J. Zhou J, et al. Chin Med J (Engl). 2002 Feb;115(2):299-301. Chin Med J (Engl). 2002. PMID: 11940354 No abstract available.

3

Thromboembolic event rate in patients with persistent or paroxysmal atrial fibrillation post circumferential pulmonary vein isolation: a single center experience in China.

Zhou JM, Liu SW, Lin JX, Nie ZN, Wu HY, Zhou J, Hao Y, Cai NS, Ge JB. Zhou JM, et al. Among authors: zhou j. Chin Med J (Engl). 2007 Jun 5;120(11):956-9. Chin Med J (Engl). 2007. PMID: 17624261

4

Rationale and design of the beta-blocker in heart failure with normal left ventricular ejection fraction (beta-PRESERVE) study.

Zhou J, Shi H, Zhang J, Lu Y, Fu M, Ge J; beta-PRESERVE Study Investigators. Zhou J, et al. Eur J Heart Fail. 2010 Feb;12(2):181-5. doi: 10.1093/eurjhf/hfp193. Eur J Heart Fail. 2010. PMID: 20083625 Free article. Clinical Trial.

5

Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction--a meta analysis of 7 prospective clinical studies.

Fu M, Zhou J, Sun A, Zhang S, Zhang C, Zou Y, Fu M, Ge J. Fu M, et al. Among authors: zhou j. Int J Cardiol. 2012 Feb 23;155(1):33-8. doi: 10.1016/j.ijcard.2011.01.081. Epub 2011 Apr 11. Int J Cardiol. 2012. PMID: 21481482

6

[Association between the urinary microalbumin/creatinine ratio and cardiovascular risk factors among elderly community subjects].

Zhou JM, Cui XT, Jin XJ, Zhou J, Ge JB. Zhou JM, et al. Among authors: zhou j. Zhonghua Xin Xue Guan Bing Za Zhi. 2011 May;39(5):463-7. Zhonghua Xin Xue Guan Bing Za Zhi. 2011. PMID: 21781604 Chinese.

7

Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice.

Zou Y, Lin L, Ye Y, Wei J, Zhou N, Liang Y, Gong H, Li L, Wu J, Li Y, Jia Z, Wu Y, Zhou J, Ge J. Zou Y, et al. Among authors: zhou j, zhou n. J Cardiovasc Pharmacol. 2012 Mar;59(3):268-80. doi: 10.1097/FJC.0b013e31823f888f. J Cardiovasc Pharmacol. 2012. PMID: 22075750

8

Association between Lipoprotein (a) level on admission and the incidence of subsequent cardiovascular events in patients with acute coronary syndrome.

Zhou J, Cui X, Jin X, Zhou J, Fu M, Zhong C, Sun A, Hu K, Fu M, Ge J. Zhou J, et al. Int J Cardiol. 2012 Jul 26;158(3):464-6. doi: 10.1016/j.ijcard.2012.05.013. Epub 2012 May 26. Int J Cardiol. 2012. PMID: 22633661 No abstract available.

9

Adiponectin through its biphasic serum level is a useful biomarker during transition from diastolic dysfunction to systolic dysfunction - an experimental study.

Fu M, Zhou J, Qian J, Jin X, Zhu H, Zhong C, Fu M, Zou Y, Ge J. Fu M, et al. Among authors: zhou j. Lipids Health Dis. 2012 Aug 30;11:106. doi: 10.1186/1476-511X-11-106. Lipids Health Dis. 2012. PMID: 22935137 Free PMC article.

10

Plasma N-terminal pro-brain natriuretic peptide levels predict new-onset atrial fibrillation in patients with acute myocardial infarction.

Dorje T, Wang X, Shao M, Zhou J, Cui X, Zhang F, Qian J, Ge J. Dorje T, et al. Among authors: zhou j. Int J Cardiol. 2013 Oct 3;168(3):3135-7. doi: 10.1016/j.ijcard.2013.04.032. Epub 2013 May 4. Int J Cardiol. 2013. PMID: 23647596 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54,471 results

Search Page

Filters